Literature DB >> 31253644

Structural basis for the recognition of nectin-like protein-5 by the human-activating immune receptor, DNAM-1.

Felix A Deuss1, Gabrielle M Watson2, Katharine J Goodall3, Isobel Leece3, Sayantani Chatterjee4, Zhihui Fu1, Morten Thaysen-Andersen4, Daniel M Andrews3, Jamie Rossjohn5, Richard Berry6.   

Abstract

Nectin and nectin-like (Necl) adhesion molecules are broadly overexpressed in a wide range of cancers. By binding to these adhesion molecules, the immunoreceptors DNAX accessory molecule-1 (DNAM-1), CD96 molecule (CD96), and T-cell immunoreceptor with Ig and ITIM domains (TIGIT) play a crucial role in regulating the anticancer activities of immune effector cells. However, within this axis, it remains unclear how DNAM-1 recognizes its cognate ligands. Here, we determined the structure of human DNAM-1 in complex with nectin-like protein-5 (Necl-5) at 2.8 Å resolution. Unexpectedly, we found that the two extracellular domains (D1-D2) of DNAM-1 adopt an unconventional "collapsed" arrangement that is markedly distinct from those in other immunoglobulin-based immunoreceptors. The DNAM-1/Necl-5 interaction was underpinned by conserved lock-and-key motifs located within their respective D1 domains, but also included a distinct interface derived from DNAM-1 D2. Mutation of the signature DNAM-1 "key" motif within the D1 domain attenuated Necl-5 binding and natural killer cell-mediated cytotoxicity. Altogether, our results have implications for understanding the binding mode of an immune receptor family that is emerging as a viable candidate for cancer immunotherapy.
© 2019 Deuss et al.

Entities:  

Keywords:  CD226 molecule; DNAX accessory molecule-1 (DNAM-1); PVR cell adhesion molecule; cancer immunotherapy; cell adhesion; immunoglobulin fold; immunology; natural killer cells (NK cells); nectin-like protein-5 (NECL-5); protein structure

Mesh:

Substances:

Year:  2019        PMID: 31253644      PMCID: PMC6699837          DOI: 10.1074/jbc.RA119.009261

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand.

Authors:  J Tormo; K Natarajan; D H Margulies; R A Mariuzza
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

Review 2.  CD28, CTLA-4 and their ligands: who does what and to whom?

Authors:  D M Sansom
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

3.  Crystal structure of the human leukocyte Fc receptor, Fc gammaRIIa.

Authors:  K F Maxwell; M S Powell; M D Hulett; P A Barton; I F McKenzie; T P Garrett; P M Hogarth
Journal:  Nat Struct Biol       Date:  1999-05

4.  Cutting edge: CD96 (tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155).

Authors:  Anja Fuchs; Marina Cella; Emanuele Giurisato; Andrey S Shaw; Marco Colonna
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

5.  Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.

Authors:  A Diefenbach; A M Jamieson; S D Liu; N Shastri; D H Raulet
Journal:  Nat Immunol       Date:  2000-08       Impact factor: 25.606

6.  Crystal structure of the HLA-Cw3 allotype-specific killer cell inhibitory receptor KIR2DL2.

Authors:  G A Snyder; A G Brooks; P D Sun
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

7.  Overexpression of the CD155 gene in human colorectal carcinoma.

Authors:  D Masson; A Jarry; B Baury; P Blanchardie; C Laboisse; P Lustenberger; M G Denis
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

8.  Intergeneric poliovirus recombinants for the treatment of malignant glioma.

Authors:  M Gromeier; S Lachmann; M R Rosenfeld; P H Gutin; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

9.  Crystal structure of the human natural killer (NK) cell activating receptor NKp46 reveals structural relationship to other leukocyte receptor complex immunoreceptors.

Authors:  Christine E Foster; Marco Colonna; Peter D Sun
Journal:  J Biol Chem       Date:  2003-09-04       Impact factor: 5.157

10.  CD155/PVR plays a key role in cell motility during tumor cell invasion and migration.

Authors:  Kevin E Sloan; Brenda K Eustace; Jean K Stewart; Carol Zehetmeier; Claudia Torella; Marina Simeone; Jennifer E Roy; Christine Unger; David N Louis; Leodevico L Ilag; Daniel G Jay
Journal:  BMC Cancer       Date:  2004-10-07       Impact factor: 4.430

View more
  3 in total

1.  The CC' loop of IgV domains of the immune checkpoint receptors, plays a key role in receptor:ligand affinity modulation.

Authors:  Shankar V Kundapura; Udupi A Ramagopal
Journal:  Sci Rep       Date:  2019-12-16       Impact factor: 4.379

2.  Antibody blockade of CD96 by distinct molecular mechanisms.

Authors:  Peter S Lee; Bryant Chau; Ishita Barman; Christine Bee; Aarti Jashnani; Jason M Hogan; Barbara Aguilar; Gavin Dollinger; Arvind Rajpal; Pavel Strop
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

Review 3.  Emergence of the CD226 Axis in Cancer Immunotherapy.

Authors:  Michael Conner; Ken W Hance; Sapna Yadavilli; James Smothers; Jeremy D Waight
Journal:  Front Immunol       Date:  2022-06-24       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.